Vagal afferent neurons in high fat diet-induced obesity; intestinal microflora, gut inflammation and cholecystokinin

Physiology and Behavior

Volumn 105, Issue 1, 2011, Pages 100-105

  de Lartigue, Guillaume ^a   de La Serre, Claire Barbier ^a   Raybould, Helen E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bacteroidales; CCK type 1 receptors; Closatridiales; Cocaine and amphetamine regulated peptide; EGR 1; Leptin; Lipopolysaccharide; Phosphorylated STAT3; Suppressor of cytokine signaling 3; TLR 4

Indexed keywords

CANNABINOID RECEPTOR; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; EARLY GROWTH RESPONSE FACTOR 1; LIPOPOLYSACCHARIDE; LONG CHAIN TRIACYLGLYCEROL; MELANIN CONCENTRATING HORMONE; MELANIN CONCENTRATING HORMONE RECEPTOR 1; STAT3 PROTEIN;

ARTICLE; BLOOD BRAIN BARRIER; BODY WEIGHT; ENERGY EXPENDITURE; ENTERITIS; FEEDING BEHAVIOR; FIRMICUTES; FOOD INTAKE; GENE EXPRESSION; HOST; HUMAN; HUNGER; INTESTINE; INTESTINE FLORA; LIPID DIET; NERVE FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHENOTYPE; PRIMARY AFFERENT DEPOLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SATIETY; SENSORY NERVE; SOLITARY TRACT NUCLEUS; STOMACH; STOMACH ACID SECRETION; STOMACH MOTILITY; UPREGULATION; VAGUS NERVE;

ANIMALS; CHOLECYSTOKININ; DIET, HIGH-FAT; EATING; INFLAMMATION; INTESTINES; NEURONS, AFFERENT; OBESITY; VAGUS NERVE;

EID: 79959212036     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2011.02.040     Document Type: Article

References (54)

1. Raybould H.E. Gut chemosensing: Interactions between gut endocrine cells and visceral afferents. Auton. Neurosci. Basic Clin. 2010, 153(1-2):41-46.
2. Sternini C., Anselmi L., Rozengurt E. Enteroendocrine cells: a site of 'taste' in gastrointestinal chemosensing. Curr. Opin. Endocrinol. Diab. Obes. 2008, 15(1):73-78. (PMCID: 2943060).
3. Raybould H.E. Nutrient sensing in the gastrointestinal tract: possible role for nutrient transporters. J. Physiol. Biochem. 2008, 64(4):349-356.
4. Blackshaw L.A., Grundy D. Locally and reflexly mediated effects of cholecystokinin-octapeptide on the ferret stomach. J. Auton. Nerv. Syst. 1991, 36(2):129-137.
5. Blackshaw L.A., Grundy D. Effects of cholecystokinin (CCK-8) on two classes of gastroduodenal vagal afferent fibre. J. Auton. Nerv. Syst. 1990, 31(3):191-201.
6. Dockray G.J. Cholecystokinin and gut-brain signalling. Regul. Pept. 2009, 155(1-3):6-10.
7. Chen D.Y., Deutsch J.A., Gonzalez M.F., Gu Y. The induction and suppression of c-fos expression in the rat brain by cholecystokinin and its antagonist L364,718. Neurosci. Lett. 1993, 149(1):91-94.
8. Day H.E., McKnight A.T., Poat J.A., Hughes J. Evidence that cholecystokinin induces immediate early gene expression in the brainstem, hypothalamus and amygdala of the rat by a CCKA receptor mechanism. Neuropharmacology 1994, 33(6):719-727.
9. Monnikes H., Lauer G., Arnold R. Peripheral administration of cholecystokinin activates c-fos expression in the locus coeruleus/subcoeruleus nucleus, dorsal vagal complex and paraventricular nucleus via capsaicin-sensitive vagal afferents and CCK-A receptors in the rat. Brain Res. 1997, 770(1-2):277-288.
10. Raybould H.E. Mechanisms of CCK signaling from gut to brain. Curr. Opin. Pharmacol. 2007, 7(6):570-574. (PMCID: 2692370).
11. Peters J.H., Simasko S.M., Ritter R.C. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin. Physiol. Behav. 2006, 89(4):477-485.
12. Gutzwiller J.P., Drewe J., Ketterer S., Hildebrand P., Krautheim A., Beglinger C. Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279(1):R189-R195.
13. Matzinger D., Degen L., Drewe J., Meuli J., Duebendorfer R., Ruckstuhl N., et al. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 2000, 46(5):688-693. (PMCID: 1727908).
14. Beglinger C., Degen L. Fat in the intestine as a regulator of appetite-role of CCK. Physiol. Behav. 2004, 83(4):617-621.
15. Raybould H.E. Nutrient tasting and signaling mechanisms in the gut. I. Sensing of lipid by the intestinal mucosa. Am. J. Physiol. 1999, 277(4 Pt 1):G751-G755.
16. Moran T.H., Katz L.F., Plata-Salaman C.R., Schwartz G.J. Disordered food intake and obesity in rats lacking cholecystokinin A receptors. Am. J. Physiol. 1998, 274(3 Pt 2):R618-R625.
17. Moran T.H. Unraveling the obesity of OLETF rats. Physiol. Behav. 2008, 94(1):71-78. (PMCID: 2399903).
18. Whited K.L., Thao D., Lloyd K.C., Kopin A.S., Raybould H.E. Targeted disruption of the murine CCK1 receptor gene reduces intestinal lipid-induced feedback inhibition of gastric function. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291(1):G156-G162.
19. Bi S., Chen J., Behles R.R., Hyun J., Kopin A.S., Moran T.H. Differential body weight and feeding responses to high-fat diets in rats and mice lacking cholecystokinin 1 receptors. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293(1):R55-R63. (PMCID: 2084469).
20. Dockray G.J. The versatility of the vagus. Physiol. Behav. 2009, 97(5):531-536.
21. de Lartigue G., Dimaline R., Varro A., Dockray G.J. Cocaine- and amphetamine-regulated transcript: stimulation of expression in rat vagal afferent neurons by cholecystokinin and suppression by ghrelin. J. Neurosci. 2007, 27(11):2876-2882.
22. Burdyga G., Lal S., Varro A., Dimaline R., Thompson D.G., Dockray G.J. Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by cholecystokinin. J. Neurosci. 2004, 24(11):2708-2715.
23. Burdyga G., Varro A., Dimaline R., Thompson D.G., Dockray G.J. Feeding-dependent depression of melanin-concentrating hormone and melanin-concentrating hormone receptor-1 expression in vagal afferent neurones. Neuroscience 2006, 137(4):1405-1415.
24. Burdyga G., de Lartigue G., Raybould H.E., Morris R., Dimaline R., Varro A., et al. Cholecystokinin regulates expression of Y2 receptors in vagal afferent neurons serving the stomach. J. Neurosci. 2008, 28(45):11583-11592. (PMCID: 2601630).
25. De Lartigue G., Dimaline R., Varro A., Raybould H., De la Serre C.B., Dockray G.J. Cocaine- and Amphetamine-Regulated Transcript Mediates the Actions of Cholecystokinin on Rat Vagal Afferent Neurons. Gastroenterology 2010, 138(4):1479-1490.
26. de Lartigue G., Lur G., Dimaline R., Varro A., Raybould H., Dockray G.J. EGR1 Is a Target for Cooperative Interactions between Cholecystokinin and Leptin, and Inhibition by Ghrelin, in Vagal Afferent Neurons. Endocrinology 2010, 151(8):3589-3599.
27. Myers M.G., Cowley M.A., Munzberg H. Mechanisms of leptin action and leptin resistance. Annu. Rev. Physiol. 2008, 70:537-556.
28. Morris D.L., Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am. J. Physiol. Endocrinol. Metab. 2009, 297(6):E1247-E1259. (PMCID: 2793049).
29. Covasa M. Deficits in gastrointestinal responses controlling food intake and body weight. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299(6):R1423-R1439.
30. Paulino G., Darcel N., Tome D., Raybould H. Adaptation of lipid-induced satiation is not dependent on caloric density in rats. Physiol. Behav. 2008, 93(4-5):930-936. (PMCID: 3007671).
31. Paulino G., Barbier de la Serre C., Knotts T.A., Oort P.J., Newman J.W., Adams S.H., et al. Increased expression of receptors for orexigenic factors in nodose ganglion of diet-induced obese rats. Am. J. Physiol. Endocrinol. Metab. 2009, 296(4):E898-E903. (PMCID: 2670626).
32. Levin B.E., Dunn-Meynell A.A., Balkan B., Keesey R.E. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am. J. Physiol. 1997, 273(2 Pt 2):R725-R730.
33. Tilg H., Moschen A.R., Kaser A. Obesity and the microbiota. Gastroenterology 2009, 136(5):1476-1483.
34. Turnbaugh P.J., Gordon J.I. The core gut microbiome, energy balance and obesity. J. Physiol. 2009, 587(Pt 17):4153-4158. (PMCID: 2754355).
35. Ley R.E. Obesity and the human microbiome. Curr. Opin. Gastroenterol. 2010, 26(1):5-11.
36. Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(31):11070-11075. (PMCID: 1176910).
37. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444(7122):1022-1023.
38. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444(7122):1027-1031.
39. Turnbaugh P.J., Backhed F., Fulton L., Gordon J.I. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host Microbe 2008, 3(4):213-223.
40. Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(3):979-984. (PMCID: 1764762).
41. Membrez M., Blancher F., Jaquet M., Bibiloni R., Cani P.D., Burcelin R.G., et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008, 22(7):2416-2426.
42. Hildebrandt M.A., Hoffmann C., Sherrill-Mix S.A., Keilbaugh S.A., Hamady M., Chen Y.Y., et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology 2009, 137(5):1716-1724. e1-2 (PMCID: 2770164).
43. de La Serre C.B., Ellis C.L., Lee J., Hartman A.L., Rutledge J.C., Raybould H.E. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 299(2):G440-G448.
44. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444(7121):860-867.
45. Erridge C., Attina T., Spickett C.M., Webb D.J. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am. J. Clin. Nutr. 2007, 86(5):1286-1292.
46. Cani P.D., Delzenne N.M. The role of the gut microbiota in energy metabolism and metabolic disease. Curr. Pharm. Des. 2009, 15(13):1546-1558.
47. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56(7):1761-1772.
48. Tsukumo D.M., Carvalho-Filho M.A., Carvalheira J.B., Prada P.O., Hirabara S.M., Schenka A.A., et al. Loss-of-function mutation in Toll-like receptor 4 prevents diet-induced obesity and insulin resistance. Diabetes 2007, 56(8):1986-1998.
49. Davis J.E., Gabler N.K., Walker-Daniels J., Spurlock M.E. Tlr-4 deficiency selectively protects against obesity induced by diets high in saturated fat. Obesity 2008, 16(6):1248-1255. (Silver Spring).
50. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57(6):1470-1481.
51. Ding S., Chi M.M., Scull B.P., Rigby R., Schwerbrock N.M., Magness S., et al. High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 2010, 5(8):e12191. (PMCID: 2922379).
52. Brown R., Imran S.A., Wilkinson M. Lipopolysaccharide (LPS) stimulates adipokine and socs3 gene expression in mouse brain and pituitary gland in vivo, and in N-1 hypothalamic neurons in vitro. J. Neuroimmunol. 2009, 209(1-2):96-103.
53. Hosoi T., Okuma Y., Matsuda T., Nomura Y. Novel pathway for LPS-induced afferent vagus nerve activation: possible role of nodose ganglion. Auton. Neurosci. 2005, 120(1-2):104-107.
54. Palazzo M., Balsari A., Rossini A., Selleri S., Calcaterra C., Gariboldi S., et al. Activation of enteroendocrine cells via TLRs induces hormone, chemokine, and defensin secretion. J Immunol 2007, 178:4296-4303.